Glycated Hemoglobin and Methods for Its Point of Care Testing

Overview

Journal Biosensors (Basel)

Specialty Biotechnology

Date 2021 Apr 3

PMID 33806493

Citations 14

Authors

Miroslav Pohanka

Affiliations

Soon will be listed here.

Abstract

Glycated hemoglobin (HbA) is a product of the spontaneous reaction between hemoglobin and elevated glucose levels in the blood. It is included among the so-called advanced glycation end products, of which is the most important for the clinical diagnosis of diabetes mellitus, and it can serve as an alternative to glycemia measurement. Compared to the diagnosis of diabetes mellitus by glycemia, the HbA level is less influenced by a short-term problem with diabetes compensation. Mass spectroscopy and chromatographic techniques are among the standard methods of HbA level measurement. Compared to glycemia measurement, there is lack of simple methods for diabetes mellitus diagnosis by means of the HbA assay using a point-of-care test. This review article is focused on the surveying of facts about HbA and its importance in diabetes mellitus diagnosis, and surveying standard methods and new methods suitable for the HbA assay under point-of-care conditions. Various bioassays and biosensors are mentioned and their specifications are discussed.

Citing Articles

The role of oxidative post-translational modifications in type 1 diabetes pathogenesis.

Alhamar G, Vinci C, Franzese V, Tramontana F, Le Goux N, Ludvigsson J Front Immunol. 2025; 16:1537405.

PMID: 40028329 PMC: 11868110. DOI: 10.3389/fimmu.2025.1537405.

Unmet needs in the treatment of type 1 diabetes: why is it so difficult to achieve an improvement in metabolic control?.

Mazzotta F, Lucaccini Paoli L, Rizzi A, Tartaglione L, Leo M, Popolla V Nutr Diabetes. 2024; 14(1):58.

PMID: 39095349 PMC: 11297181. DOI: 10.1038/s41387-024-00319-w.

Advances in electrochemical biosensors employing carbon-based electrodes for detection of biomarkers in diabetes mellitus.

Zuliska S, Maksum I, Einaga Y, Kadja G, Irkham I ADMET DMPK. 2024; 12(3):487-527.

PMID: 39091901 PMC: 11289508. DOI: 10.5599/admet.2361.

Developing a Portable Autofluorescence Detection System and Its Application in Biological Samples.

Zhou J, Li Y, Zhang J, Cai F Sensors (Basel). 2024; 24(11).

PMID: 38894145 PMC: 11174582. DOI: 10.3390/s24113351.

A Comparative Evaluation of HbA1c Measurement Methods and Their Implications for Diabetes Management.

Yun H, Park J, Kim J Diagnostics (Basel). 2023; 13(22).

PMID: 37998585 PMC: 10670690. DOI: 10.3390/diagnostics13223449.

References

Sardini E, Serpelloni M, Tonello S . Printed Electrochemical Biosensors: Opportunities and Metrological Challenges. Biosensors (Basel). 2020; 10(11). PMC: 7694196. DOI: 10.3390/bios10110166. View

Ernst E, Wolfe P, Stahura C, Edwards K . Technical considerations to development of serological tests for SARS-CoV-2. Talanta. 2020; 224:121883. PMC: 7654332. DOI: 10.1016/j.talanta.2020.121883. View

Singh V, Bali A, Singh N, Jaggi A . Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014; 18(1):1-14. PMC: 3951818. DOI: 10.4196/kjpp.2014.18.1.1. View

Winston A . Eating Disorders and Diabetes. Curr Diab Rep. 2020; 20(8):32. DOI: 10.1007/s11892-020-01320-0. View

Bryskiewicz M, Majkowska L . [Glycated hemoglobin (HbA1c) as a standard diagnostic criterium for diabetes?]. Pol Merkur Lekarski. 2011; 30(176):150-4. View

Ito M, Sano K, Koga M . 3 cases of variant hemoglobin Hb A2-Niigata detected by falsely high HbA1c values. Clin Chim Acta. 2020; 510:656-658. DOI: 10.1016/j.cca.2020.08.036. View

Mejia-Salazar J, Oliveira Jr O . Plasmonic Biosensing. Chem Rev. 2018; 118(20):10617-10625. DOI: 10.1021/acs.chemrev.8b00359. View

Okamoto T, Shima H, Noma Y, Komatsu M, Azuma H, Miya K . Hereditary spherocytosis diagnosed with extremely low glycated hemoglobin compared to plasma glucose levels. Diabetol Int. 2021; 12(2):229-233. PMC: 7943674. DOI: 10.1007/s13340-020-00456-4. View

Appel E, Moltke I, Jorgensen M, Bjerregaard P, Linneberg A, Pedersen O . Genetic determinants of glycated hemoglobin levels in the Greenlandic Inuit population. Eur J Hum Genet. 2018; 26(6):868-875. PMC: 5974304. DOI: 10.1038/s41431-018-0109-3. View

10.

Sun D, Wu Y, Chang S, Chen C, Liu J . Investigation of the recognition interaction between glycated hemoglobin and its aptamer by using surface plasmon resonance. Talanta. 2020; 222:121466. DOI: 10.1016/j.talanta.2020.121466. View

11.

Jain U, Chauhan N . Glycated hemoglobin detection with electrochemical sensing amplified by gold nanoparticles embedded N-doped graphene nanosheet. Biosens Bioelectron. 2016; 89(Pt 1):578-584. DOI: 10.1016/j.bios.2016.02.033. View

12.

Lingervelder D, Koffijberg H, Kusters R, IJzerman M . Health Economic Evidence of Point-of-Care Testing: A Systematic Review. Pharmacoecon Open. 2021; 5(2):157-173. PMC: 8160040. DOI: 10.1007/s41669-020-00248-1. View

13.

Han Y, Kim K, Park Y, Song S, Yang Y, Lee K . Boronate-functionalized hydrogel as a novel biosensing interface for the glycated hemoglobin A1c (HbA) based on the competitive binding with signaling glycoprotein. Mater Sci Eng C Mater Biol Appl. 2017; 77:1160-1169. DOI: 10.1016/j.msec.2017.04.043. View

14.

Konwar A, Borse V . Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic. Sens Int. 2021; 1:100015. PMC: 7280827. DOI: 10.1016/j.sintl.2020.100015. View

15.

Mulder D, Phiri M, Vorster B . Gold Nanostar Colorimetric Detection of Fructosyl Valine as a Potential Future Point of Care Biosensor Candidate for Glycated Haemoglobin Detection. Biosensors (Basel). 2019; 9(3). PMC: 6784361. DOI: 10.3390/bios9030100. View

16.

Katwal P, Jirjees S, Htun Z, Aldawudi I, Khan S . The Effect of Anemia and the Goal of Optimal HbA1c Control in Diabetes and Non-Diabetes. Cureus. 2020; 12(6):e8431. PMC: 7336595. DOI: 10.7759/cureus.8431. View

17.

Mauriz E . Clinical Applications of Visual Plasmonic Colorimetric Sensing. Sensors (Basel). 2020; 20(21). PMC: 7663786. DOI: 10.3390/s20216214. View

18.

Spaeth B, Shephard M, Schatz S . Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural Remote Health. 2014; 14(4):2849. View

19.

Lin H, Yi J . Current Status of HbA1c Biosensors. Sensors (Basel). 2017; 17(8). PMC: 5579747. DOI: 10.3390/s17081798. View

20.

Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S . An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta. 2002; 324(1-2):61-71. DOI: 10.1016/s0009-8981(02)00207-3. View